Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on SITCP Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107698590A details asymmetric cyclization for high-purity nucleosides. Offers cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN107698590B details a novel asymmetric [3+2] cyclization for chiral carbocyclic purine nucleosides, offering high yields and enantioselectivity for reliable pharmaceutical intermediate supply.